Clene stock rallies 52% post-market on MS drug data
https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare
Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
0
Are You Looking for a High-Growth Dividend Stock?
https://www.zacks.com/stock/news/2259447/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2259447
Apr 22, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes? Let's find out.
0
Virtu Financial (VIRT) Q1 Earnings Beat on Interest Income
https://www.zacks.com/stock/news/2261599/virtu-financial-virt-q1-earnings-beat-on-interest-income?cid=CS-ZC-FT-analyst_blog|earnings_article-2261599
Apr 24, 2024 - Virtu Financial's (VIRT) Q1 results benefit from revenue growth in the Market Making unit, partly offset by increased communication and data processing costs.
0
Morgan Stanley (MS) Seeks Job Cuts in Its Wealth Management Unit
https://www.zacks.com/stock/news/2226963/morgan-stanley-ms-seeks-job-cuts-in-its-wealth-management-unit?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2226963
Feb 15, 2024 - Morgan Stanley (MS) plans to cut hundreds of jobs in its wealth management unit amid uncertainty about the trajectory of interest rate cuts.
0
This Electric Vehicle Stock Has 75% Upside, According to 1 Wall Street Analyst
https://www.fool.com/investing/2024/02/25/this-electric-vehicle-stock-has-78-upside-accordin/?source=iedfolrf0000001
Feb 25, 2024 - Investors continue to underestimate the company's potential, according to a team of pundits.
0
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
0
Citigroup (C) Seeks 286 Job Cuts of New York-Based Employees
https://www.zacks.com/stock/news/2234827/citigroup-c-seeks-286-job-cuts-of-new-york-based-employees?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234827
Mar 01, 2024 - Citigroup (C) is planning to cut 286 positions across three units in New York to reduce costs.
0
Morgan Stanley (MS) Axes China Unit Staff Amid Market Failure
https://www.zacks.com/stock/news/2237569/morgan-stanley-ms-axes-china-unit-staff-amid-market-failure?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2237569
Mar 07, 2024 - Morgan Stanley (MS) lays off 9% of its staff at its asset management business unit in China as the nation witnesses a long-running stock market collapse.
0
MS drug developer Contineum files for $150M IPO
https://seekingalpha.com/news/4081227-ms-drug-developer-contineum-files-for-150m-ipo?source=feed_sector_healthcare
Mar 19, 2024 - Contineum Therapeutics (CTNM), which is developing therapies for multiple sclerosis and idiopathic pulmonary fibrosis, has filed for a proposed $150M IPO. Read more here.
0
Barclays (BCS) Plans to Slash Hundreds of Investment Bank Jobs
https://www.zacks.com/stock/news/2244310/barclays-bcs-plans-to-slash-hundreds-of-investment-bank-jobs?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2244310
Mar 21, 2024 - Continuing with its efforts to reduce costs and boost the division's profits, Barclays (BCS) plans to cut hundreds of jobs in the investment banking arm.
0
<Page 2